"Dr. Jay L. Schwartz welcomes you to Schwartz Laser Eye Center, a full-service ophthalmology practice offering the latest in refractive surgery and general eye care. We are confident that we can take care of all of your ophthalmology needs, as well as the needs of your family. Whether you are looking for a solution to nearsightedness, farsightedness, astigmatism, presbyopia, cataracts, keratoconus or a similar condition, we can help. With sharper vision, you can focus on what’s truly important in life — without the hassle of contact lenses or glasses."

During the past decade, Schwartz Laser Eye Center conducted 9 clinical trials. In the 10-year time frame, 9 clinical trials started and 4 clinical trials were completed, i.e. on average, 44.4% percent of trials that started reached the finish line to date. In the past 5 years, 3 clinical trials started and 4 clinical trials were completed. i.e. 133.3% of trials that started reached the finish line.

Out of the total clinical trials conducted in "Schwartz Laser Eye Center" #1 sponsor was "Cxlusa" with 4 trials, followed by "Allergan" with 1 trials sponsored, "Formosa Pharmaceuticals, Inc." with 1 trials sponsored, "Innovative Medical" with 1 trials sponsored and "Kala Pharmaceuticals, Inc." with 1 trials sponsored. Other sponsors include 2 different institutions and companies that sponsored additional 12 trials in total.

In terms of collaborators to trials, out of the total clinical trials conducted in "Schwartz Laser Eye Center" #1 collaborator was "Allergan" with 1 trials as a collaborator, "Carl Zeiss Meditec, Inc." with 1 trials as a collaborator, "Optovue" with 1 trials as a collaborator and "ThromboGenics" with 1 trials as a collaborator. Other collaborators include -4 different institutions and companies that were collaborators in the rest 4 trials.

According to Clinical.Site data, the most researched conditions in "Schwartz Laser Eye Center" are "Dry Eye" (3 trials), "Keratoconus" (2 trials), "Allergic Conjunctivitis" (1 trials), "Bacterial Conjunctivitis" (1 trials) and "Blepharitis" (1 trials). Many other conditions were trialed in "Schwartz Laser Eye Center" in a lesser frequency.

Most popular intervention types in "Schwartz Laser Eye Center" are "Drug" (10 trials), "Device" (2 trials), "Other" (2 trials) and "Combination Product" (1 trials). Other intervention types were less common.

The name of intervention was led by "Placebo" (4 trials), "0.005% Lacripep" (1 trials), "0.01% Lacripep" (1 trials), "APP13007, 0.05%" (1 trials) and "Azithromycin ophthalmic solution, 1%" (1 trials). Other intervention names were less common.

The vast majority of trials in "Schwartz Laser Eye Center" are 15 trials for "All" genders.

Currently, there are NaN active trials in "Schwartz Laser Eye Center". undefined are not yet recruiting, undefined are recruiting, 1 are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were 12 completed trials in Schwartz Laser Eye Center, undefined suspended trials, and 2 terminated clinical trials to date.

Out of the total trials that were conducted in Schwartz Laser Eye Center, 1 "Phase 1" clinical trials were conducted, 3 "Phase 2" clinical trials and 5 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 1 trials, and there were also 2 trials that are defined as “Not Applicable".